MICHELIE LEVRIER: Open Payments
NPI 1669945747 · SAINT CLOUD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,735 in 96 payments from 12 companies in 2025. Trend: 2023 $1,908 · 2024 $1,826 · 2025 $1,735
Food & beverage: $1,735
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $397 |
| Axsome Therapeutics, Inc. | 15 | $356 |
| Neurocrine BioSciences, Inc. | 11 | $210 |
| Alkermes, Inc. | 9 | $175 |
| Vanda Pharmaceuticals Inc. | 8 | $154 |
| Otsuka America Pharmaceutical, Inc. | 8 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $103 |
| Lundbeck LLC | 4 | $89 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
| Corium, LLC | 2 | $28 |
Products named: VRAYLAR, Auvelity, INGREZZA, FANAPT, REXULTI, CAPLYTA, ABILIFY ASIMTUFII, LYBALVI.
Industry payments across FL — which companies pay providers there.
